24,99 €
inkl. MwSt.

Versandfertig in 1-2 Wochen
payback
12 °P sammeln
  • Broschiertes Buch

This monograph reveals new links in the pathogenesis and lengthening the duration of the anhydrous period by increasing glutathione peroxidase, folic acid, alpha fetoprotein, fibronectin, improving the indications of antioxidant protection, as well as normalizing the LPO/AOD balance, which allow us to identify new aspects of the pathogenesis of this pathology. Confirmed by the use in the study of modern, complementary clinical, biochemical, statistical methods, as well as a sufficient number of examined patients, the improvement of diagnostic and prognostic criteria for premature rupture of…mehr

Produktbeschreibung
This monograph reveals new links in the pathogenesis and lengthening the duration of the anhydrous period by increasing glutathione peroxidase, folic acid, alpha fetoprotein, fibronectin, improving the indications of antioxidant protection, as well as normalizing the LPO/AOD balance, which allow us to identify new aspects of the pathogenesis of this pathology. Confirmed by the use in the study of modern, complementary clinical, biochemical, statistical methods, as well as a sufficient number of examined patients, the improvement of diagnostic and prognostic criteria for premature rupture of membranes in pregnant women, which are justified by a set of statistical analysis methods, as well as their correct application; comparison of the obtained results with foreign and domestic studies; conclusion, confirmation of the obtained results by authorized structures.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Autorenporträt
Ismailova Savriniso Sultanovna, geboren 1967 - Assistentin der Abteilung für Geburtshilfe und Gynäkologie, Neonatologie und Endokrinologie der Fakultät für Verbesserung und Umschulung von Ärzten des staatlichen medizinischen Instituts, Kandidatin für medizinische Wissenschaften, Autorin von mehr als 31 wissenschaftlichen Arbeiten, davon 6 sind ausländische, 2 sind Rationalisierungsvorschläge, 3 sind methodische Empfehlungen, 2 Patente.